A single-item measure of health-related quality-of-life for HIV-infected patients in routine clinical care

AIDS Patient Care and STDs

Volumn 20, Issue 3, 2006, Pages 161-174

  Crane, Heidi M ^a   Van Rompaey, Stephen E ^a   Dillingham, Peter W ^a   Herman, Eric ^a   Diehr, Paula ^a   Kitahata, Mari M ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

ACCURACY; ADULT; AGED; ANALYTICAL PARAMETERS; ARTICLE; CD4 LYMPHOCYTE COUNT; CLINICAL CARE; CONSTRUCT VALIDITY; DEMOGRAPHY; DISCRIMINATIVE ABILITY; EDUCATION; FEMALE; HEALTH RELATED QUALITY OF LIFE 21 ITEM QUESTIONNAIRE; HEALTH STATUS; HEALTH SURVEY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MULTIPLE REGRESSION; PATIENT CARE; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; SOCIAL ASPECT; SYMPTOM BURDEN; SYMPTOMATOLOGY; VIRUS LOAD;

ADULT; CD4 LYMPHOCYTE COUNT; FEMALE; HEALTH STATUS; HIV INFECTIONS; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SOCIAL CLASS;

EID: 33645376461     PISSN: 10872914     EISSN: None     Source Type: Journal    
DOI: 10.1089/apc.2006.20.161     Document Type: Article

References (58)

1. Bjordal K. Impact of quality of life measurement in daily clinical practice. Ann Oncol 2004;15(Suppl 4):iv279-282.
2. Grossman HA, Sullivan PS, Wu AW. Quality of life and HIV: Current assessment tools and future directions for clinical practice. AIDS Read 2003;13:583-590, 595-597.
3. Detmar SB, Muller MJ, Schornagel JH, Wever LD, Aaronson NK. Health-related quality-of-life assessments and patient-physician communication: A randomized controlled trial. JAMA 2002;288:3027-3034.
4. Higginson IJ, Carr AJ. Measuring quality of life: Using quality of life measures in the clinical setting. BMJ 2001;322:1297-1300.
5. Nieuwkerk PT, Gisolf EH, Reijers MH, Lange JM, Danner SA, Sprangers MA. Long-term quality of life outcomes in three antiretroviral treatment strategies for HIV-1 infection. AIDS 2001;15:1985-1991.
6. Wu AW, Rubin HR, Mathews WC, et al. Functional status and well-being in a placebo-controlled trial of zidovudine in early symptomatic HIV infection. J Acquir Immune Defic Syndr 1993;6:452-458.
7. Revicki DA, Moyle G, Stellbrink HJ, Barker C. Quality of life outcomes of combination zalcitabine-zidovudine, saquinavir-zidovudine, and saquinavir-zalcitabine-zidovudine therapy for HIV-infected adults with CD4 cell counts between 50 and 350 per cubic millimeter. PISCES (SV14604) Study Group. AIDS 1999;13:851-858.
8. Bucciardini R, Wu AW, Floridia M, et al. Quality of life outcomes of combination zidovudine-didanosine-nevirapine and zidovudine-didanosine for antiretroviral-naive advanced HIV-infected patients. AIDS 2000;14:2567-2574.
9. Justice AC, Rabeneck L, Hays RD, Wu AW, Bozzette SA. Sensitivity, specificity, reliability, and clinical validity of provider-reported symptoms: A comparison with self-reported symptoms. Outcomes Committee of the AIDS Clinical Trials Group. J Acquir Immune Defic Syndr 1999;21:126-133.
10. Justice AC, Chang CH, Rabeneck L, Zackin R. Clinical importance of provider-reported HIV symptoms compared with patient-report. Med Care 2001;39:397-408.
11. Fumaz CR, Tuldra A, Ferrer MJ, et al. Quality of life, emotional status, and adherence of HIV-1-infected patients treated with efavirenz versus protease inhibitor-containing regimens. J Acquir Immune Defic Syndr 2002;29:244-253.
12. Bing EG, Hays RD, Jacobson LP, et al. Health-related quality of life among people with HIV disease: results from the Multicenter AIDS Cohort Study. Qual Life Res 2000;9:55-63.
13. Hays RD, Cunningham WE, Sherbourne CD, et al. Health-related quality of life in patients with human immunodeficiency virus infection in the United States: Results from the HIV Cost and Services Utilization Study. Am J Med 2000;108:714-722.
14. Shahriar J, Delate T, Hays RD, Coons SJ. Commentary on using the SF-36 or MOS-HIV in studies of persons with HIV disease. Health Qual Life Outcomes 2003;1:25.
15. Davis EA, Pathak DS. Psychometric evaluation of four HIV disease-specific quality-of-life instruments. Ann Pharmacother 2001;35:546-552.
16. Bozzette SA, Hays RD, Berry SH, Kanouse DE, Wu AW. Derivation and properties of a brief health status assessment instrument for use in HIV disease. J Acquir Immune Defic Syndr Hum Retrovirol 1995;8:253-265.
17. Diehr P, Williamson J, Patrick DL, Bild DE, Burke GL. Patterns of self-rated health in older adults before and after sentinel health events. J Am Geriatr Soc 2001;49:36-44.
18. Manor O, Matthews S, Power C. Self-rated health and limiting longstanding illness: Inter-relationships with morbidity in early adulthood. Int J Epidemiol 2001;30:600-607.
19. Manor O, Matthews S, Power C. Dichotomous or categorical response? Analysing self-rated health and lifetime social class. Int J Epiderniol 2000;29:149-157.
20. Eriksson I, Unden AL, Elofsson S. Self-rated health. Comparisons between three different measures. Results from a population study. Int J Epidemiol 2001;30:326-333.
21. Mackenbach JP, Simon JG, Looman CW, Joung IM. Self-assessed health and mortality: could psychosocial factors explain the association? Int J Epidemiol 2002;31:1162-1168.
22. Idler EL, Russell LB, Davis D. Survival, functional limitations, and self-rated health in the NHANES I Epidemiologic Follow-up Study, 1992. First National Health and Nutrition Examination Survey. Am J Epidemiol 2000;152:874-883.
23. Grant MD, Piotrowski ZH, Chappell R. Self-reported health and survival in the Longitudinal Study of Aging, 1984-1986. J Clin Epidemiol 1995;48:375-387.
24. Idler EL, Benyamini Y. Self-rated health and mortality: A review of twenty-seven community studies. J Health Soc Behav 1997;38:21-37.
25. Wu AW, Rubin HR, Mathews WC, et al. A health status questionnaire using 30 items from the Medical Outcomes Study. Preliminary validation in persons with early HIV infection. Med Care 1991;29:786-798.
26. O'Dell MW, Lubeck DP, O'Driscoll P, Matsuno S. Validity of the Karnofsky Performance Status in an HIV-infected sample. J Acquir Immune Defic Syndr Hum Retrovirol 1995;10:350-357.
27. Freedberg KA, Losina E, Weinstein MC, et al. The cost effectiveness of combination antiretroviral therapy for HIV disease. N Engl J Med 2001;344:824-831.
28. Bozzette SA, Hays RD, Berry SH, Kanouse DE. A Perceived Health Index for use in persons with advanced HIV disease: derivation, reliability, and validity. Med Care 1994;32:716-731.
29. Guyatt GH, Naylor CD, Juniper E, Heyland DK, Jaeschke R, Cook DJ. Users' guides to the medical literature. XII. How to use articles about health-related quality of life. Evidence-Based Medicine Working Group. JAMA 1997;277:1232-1237.
30. Guyatt GH, Kirshner B, Jaeschke R. A methodologic framework for health status measures: clarity or over-simplification? J Clin Epidemiol 1992;45:1353-1355.
31. Gill CJ, Griffith JL, Jacobson D, Skinner S, Gorbach SL, Wilson IB. Relationship of HIV viral loads, CD4 counts, and HAART use to health-related quality of life. J Acquir Immune Defic Syndr 2002;30:485-492.
32. Cunningham WE, Shapiro MF, Hays RD, et al. Constitutional symptoms and health-related quality of life in patients with symptomatic HIV disease. Am J Med 1998;104:129-136.
33. Justice AC, Gifford A, Rabeneck L, et al. Development and validation of a self-completed HIV symptom index. J Clin Epidemiol 2001;54:S77-S90.
34. Call SA, Klapow JC, Stewart KE, et al. Health-related quality of life and virologic outcomes in an HIV clinic. Qual Life Res 2000;9:977-985.
35. McDonnell KA, Gielen AC, Wu AW, O'Campo P, Faden R. Measuring health related quality of life among women living with HIV. Qual Life Res 2000;9:931-940.
36. Hughes TE, Kaplan RM, Coons SJ, Draugalis JR, Johnson JA, Patterson TL. Construct validities of the Quality of Well-Being Scale and the MOS-HIV-34 Health Survey for HIV-infected patients. Med Decis Making 1997;17:439-446.
37. Murri R, Ammassari A, Fantoni M, et al. Disease-related factors associated with health-related quality of life in people with nonadvanced HIV disease assessed using an Italian version of the MOS-HIV Health Survey. J Acquir Immune Defic Syndr Hum Retrovirol 1997;16:350-356.
38. Revicki DA, Sorensen S, Wu AW. Reliability and validity of physical and mental health summary scores from the Medical Outcomes Study HIV Health Survey. Med Care 1998;36:126-137.
39. Globe DR, Hays RD, Cunningham WE. Associations of clinical parameters with health-related quality of life in hospitalized persons with HIV disease. AIDS Care 1999;11:71-86.
40. De Boer JB, Sprangers MA, Aaronson NK, Lange JM, van Dam FS. A study of the reliability, validity and responsiveness of the HIV overview of problems evaluation system (HOPES) in assessing the quality of life of patients with AIDS and symptomatic HIV infection. Qual Life Res 1996;5:339-347.
41. Lorenz KA, Shapiro MF, Asch SM, Bozzette SA, Hays RD. Associations of symptoms and health-related quality of life: findings from a national study of persons with HIV infection. Ann Intern Med 2001;134:854-860.
42. Lubeck DP, Fries JF. Assessment of quality of life in early stage HIV-infected persons: Data from the AIDS Time-oriented Health Outcome Study (ATHOS). Qual Life Res 1997;6:494-506.
43. Holmes WC, Shea JA. A new HIV/AIDS-targeted quality of life (HAT-QoL) instrument: Development, reliability, and validity. Med Care 1998;36:138-154.
44. Chandola T, Jenkinson C. Validating self-rated health in different ethnic groups. Ethn Health 2000;5:151-191.
45. Manderbacka K, Lahelma E, Martikainen P. Examining the continuity of self-rated health. Int J Epidemiol 1998;27:208-213.
46. Martin BK, Kaplan Gilpin AM, Jabs DA, Wu AW. Reliability, validity, and responsiveness of general and disease-specific quality of life measures in a clinical trial for cytomegalovirus retinitis. J Clin Epidemiol 2001;54:376-386.
47. Han C, Pulling CC, Telke SE, Huppler Hullsiek K. Assessing the utility of five domains in SF-12 Health Status Questionnaire in an AIDS clinical trial. AIDS 2002;16:431-439.
48. Hays RD, Cunningham WE, Sherbourne CD, et al. Health-related quality of life in patients with human immunodeficiency virus infection in the United States: Results from the HIV Cost and Services Utilization Study. Am J Med 2000;108:714-722.
49. Wilson IB, Cleary PD. Clinical predictors of functioning in persons with acquired immunodeficiency syndrome. Med Care 1996;34:610-623.
50. Mannheimer SB, Matts J, Telzak E, et al. Quality of life in HIV-infected individuals receiving antiretroviral therapy is related to adherence. AIDS Care 2005;17:10-22.
51. Holzerner WL, Corless IB, Nokes KM, et al. Predictors of self-reported adherence in persons living with HIV disease. AIDS Patient Care STD 1999;13:185-197.
52. Carballo E, Cadarso-Suarez C, Carrera I, et al. Assessing relationships between health-related quality of life and adherence to antiretroviral therapy. Qual Life Res 2004;13:587-599.
53. Bangsberg DR, Hecht FM, Charlebois ED, et al. Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS 2000;14:357-366.
54. Montaner JS, Reiss P, Cooper D, et al. A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients: The INCAS Trial. Italy, The Netherlands, Canada and Australia Study. JAMA 1998;279:930-937.
55. Haubrich RH, Little SJ, Currier JS, et al. The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response. California Collaborative Treatment Group. AIDS 1999;13:1099-1107.
56. Gifford AL, Bormann JE, Shively MJ, Wright BC, Richman DD, Bozzette SA. Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens. J Acquir Immune Defic Syndr 2000;23:386-395.
57. Knobel H, Guelar A, Carmona A, et al. Virologic outcome and predictors of virologic failure of highly active antiretroviral therapy containing protease inhibitors. AIDS Patient Care STD 2001;15:193-199.
58. Jia H, Uphold CR, Wu S, Chen GJ, Duncan PW. Predictors of changes in health-related quality of life among men with HIV infection in the HAART era. AIDS Patient Care STDs 2005;19:395-405.